Healthcare & Life Sciences
Probmet Therapeutics
Denmarkprobmet.com/
Probmet Therapeutics is a Healthcare & Life Sciences startup based in Denmark, most recent round Seed, 1 tracked investor.
seed
seed
Stage
1
Investors
About Probmet Therapeutics
Probmet Therapeutics is a company headquartered in Denmark. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Probmet Therapeutics is a university spin-out based in Copenhagen developing peptide-based targeted therapies for breast cancer brain metastases by targeting the receptor ADAM22; their lead peptide was developed in silico, crosses the blood–brain barrier, and has shown efficacy in human and animal models.
Explore Probmet Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.